Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at TroVax for ovarian cancer, primary peritoneal cancer and fallopian tube cancer that has come back (TRIOC)

Overview

Cancer types:

Ovarian cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at a vaccine called TroVax for the following cancers that have come back after initial treatment:

  • ovarian cancer

  • primary peritoneal cancer

  • fallopian tube cancer

Recruitment start: 26 November 2013

Recruitment end: 31 October 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Agnieszka Michael

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Oxford Biomedica

University College London (UCL)

Other information

This is Cancer Research UK trial number CRUKE/11/059.

Last reviewed: 2 October 2023

CRUK internal database number: 9192

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.